Ovarian Tumor Cells and Complement Inhibitors
Author Information
Author(s): Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjørge L, Bützow R, Zipfel P F, Meri S
Primary Institution: University Central Hospital, Helsinki, Finland
Hypothesis
Do ovarian tumor cells secrete soluble complement inhibitors that promote C3b inactivation?
Conclusion
Ovarian tumor cells produce factor H and factor H-like protein, which may help them evade immune attacks.
Supporting Evidence
- Ovarian tumor cells were found to secrete higher levels of factor H-like protein compared to normal serum.
- Immunohistochemical analyses showed the presence of FHL-1 and factor H in ovarian tumors.
- Cell lines SK-OV-3 and Caov-3 produced both factor H and FHL-1.
- Ascites samples from ovarian cancer patients contained significantly higher levels of factor H and FHL-1 than control samples.
Takeaway
Ovarian cancer cells can make special proteins that help them hide from the body's defenses, making it harder to treat the cancer.
Methodology
The study involved analyzing ascites and tumor samples from ovarian cancer patients and cultured tumor cell lines for the presence of complement inhibitors.
Potential Biases
Potential bias in sample selection and the specific cell lines used.
Limitations
The study was limited to specific cell lines and may not represent all ovarian tumors.
Participant Demographics
Patients with ovarian cancer, median age 63.5 years, range 30-75 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website